HPV
Unknown
1,306 enrolled
CESTA
Phase 3 Unknown
1,500 enrolled
Immunogenicity of 9-valent HPV Vaccine
Phase 4 Unknown
120 enrolled
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Phase 4 Unknown
120 enrolled
Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses
Phase NA Unknown
150 enrolled
A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine
Phase 3 Unknown
1,260 enrolled
The KEN SHE Study on HPV-vaccine Efficacy
Phase 4 Unknown
2,275 enrolled
HPV Viral Load in Predicting the Prognosis of LSIL
Unknown
1,000 enrolled
A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
Unknown
4,000 enrolled
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
Unknown
1,000 enrolled
ELEVATE AS
Phase NA Unknown
1,048 enrolled
Understanding Women's Values in Managing Human Papillomavirus (HPV)
Unknown
20 enrolled
PrENT
Unknown
10,000 enrolled
Self-Collected Swabs for Primary Human Papilloma Virus (HPV) Screening
Unknown
84 enrolled
The Influence of Oral Probiotic on the Vaginal Flora and Microenvironment Alteration in the Vaginosis Infection Women
Phase NA Unknown
76 enrolled
PrevHPV-TG
Unknown
200 enrolled
Evaluation of the Prevalence of Oral HPV Infection in Patients Who Are Positive to the PAP-test
Unknown
50 enrolled
Treatment of HPV Infection in Perimenopausal and Postmenopausal Women
Phase 4 Unknown
150 enrolled
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
Phase NA Unknown
17,000 enrolled
AUTOCol
Phase NA Unknown
200 enrolled
"Lactobacillus Crispatus M247, LSIL and Microbiota"
Phase 4 Unknown
90 enrolled
HYPER3
Unknown
200 enrolled
HYPER4
Unknown
500 enrolled
Prognostic Study of HPV Virus Integration in Women With HSIL
Unknown
1,000 enrolled
Phase I Clinical Trial of a Candidate HPV Vaccine
Phase 1 Unknown
40 enrolled
A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine
Phase 3 Unknown
12,000 enrolled
Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
Phase 3 Unknown
1,200 enrolled
Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women
Unknown
2,200 enrolled
SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia
Phase NA Unknown
55,176 enrolled
CUTE-IPS
Phase NA Unknown
400 enrolled
Cervical Cancer Screening Strategies
Unknown
10,000 enrolled
AIMA-CC
Phase NA Unknown
3,000 enrolled
DepIST-H
Unknown
200 enrolled
Urine-hrHPV
Unknown
1,000 enrolled
Human Papilloma Virus (HPV) Self-collection and Women Adherence
Phase NA Unknown
80 enrolled
PAPLOR
Phase NA Unknown
385 enrolled
Changes in the Prevalence of Oncogenic HPV Types
Unknown
1,500 enrolled
Nabothian Cyst Protects or Facilitates Against Cervical Cancer
Unknown
1,005 enrolled
IVIHPV1
Phase NA Unknown
18,000 enrolled
HPV Prevalence in 16-20 Year Old Males
Unknown
681 enrolled
VENUS
Unknown
508 enrolled
Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
Unknown
104 enrolled
A Cohort Study for the Following up of Conization
Unknown
10,000 enrolled
Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection
Unknown
151 enrolled
Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
Phase NA Unknown
300 enrolled
HPV
Phase NA Unknown
1,600 enrolled
Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyproneâ„¢) on the Clearance of Verruca Vulgaris (Common Warts)
Phase 2 Unknown
83 enrolled
HPV
Phase NA Unknown
227 enrolled
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRXâ„¢ Anorectal Wand
Phase 2 Unknown
70 enrolled
Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)
Phase 2 Unknown
134 enrolled